4/22
08:05 am
ebs
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
Medium
Report
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
4/17
10:58 am
ebs
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses [Yahoo! Finance]
Low
Report
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses [Yahoo! Finance]
4/11
09:06 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Low
Report
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
3/28
08:28 am
ebs
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis [Yahoo! Finance]
3/28
08:15 am
ebs
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Medium
Report
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
3/25
10:11 am
ebs
National Safety Council Expands Efforts to Combat Overdoses in the Workplace [Yahoo! Finance]
Low
Report
National Safety Council Expands Efforts to Combat Overdoses in the Workplace [Yahoo! Finance]
3/25
08:16 am
ebs
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility [Yahoo! Finance]
3/25
08:05 am
ebs
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Medium
Report
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
3/7
02:12 pm
ebs
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/7
01:53 pm
ebs
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales [Yahoo! Finance]
Neutral
Report
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales [Yahoo! Finance]
3/7
11:41 am
ebs
Benchmark upgrades Emergent Biosolutions to Buy [Seeking Alpha]
Neutral
Report
Benchmark upgrades Emergent Biosolutions to Buy [Seeking Alpha]
3/7
10:43 am
ebs
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:18 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Medium
Report
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
3/6
11:53 pm
ebs
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
04:36 pm
ebs
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results [Yahoo! Finance]
High
Report
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results [Yahoo! Finance]
3/6
04:31 pm
ebs
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
High
Report
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
2/29
07:00 am
ebs
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
Low
Report
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
2/27
12:02 pm
ebs
New CEO Appointment A Clear Positive For Emergent BioSolutions [Seeking Alpha]
Medium
Report
New CEO Appointment A Clear Positive For Emergent BioSolutions [Seeking Alpha]
2/27
08:30 am
ebs
Cholera Vaccines Market to Reach USD 167.3 Million by 2030, Fueled by a CAGR of 9.0% from 2030 | MarketDigits [Yahoo! Finance]
High
Report
Cholera Vaccines Market to Reach USD 167.3 Million by 2030, Fueled by a CAGR of 9.0% from 2030 | MarketDigits [Yahoo! Finance]
2/21
07:38 am
ebs
UPDATE 1-Emergent appoints former Bausch + Lomb CEO to head company [Yahoo! Finance]
High
Report
UPDATE 1-Emergent appoints former Bausch + Lomb CEO to head company [Yahoo! Finance]
2/21
07:07 am
ebs
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO [Yahoo! Finance]
High
Report
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO [Yahoo! Finance]
2/21
07:00 am
ebs
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
High
Report
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
2/6
12:43 pm
ebs
Global Lipid Nanoparticle Manufacturing Market 2023-2035: Partnerships and Collaborations on the Rise for Lipid Nanoparticle Manufacturing [Yahoo! Finance]
Low
Report
Global Lipid Nanoparticle Manufacturing Market 2023-2035: Partnerships and Collaborations on the Rise for Lipid Nanoparticle Manufacturing [Yahoo! Finance]